Literature DB >> 19876071

A reappraisal of the significance of largest basal diameter of posterior uveal melanoma.

B Damato1, S E Coupland.   

Abstract

OBJECTIVES: To evaluate the significance of the largest tumour diameter (LTD) of posterior uveal melanomas (ie, involving choroid), correlating this feature with histological and cytogenetic predictors and mortality.
METHODS: Patients with posterior uveal melanoma were included. LTD was measured by echography and correlated with histological and cytogenetic findings and metastatic death.
RESULTS: The cohort comprised 1776 patients with a median age of 60 years, a median tumour diameter of 14.0 mm, and a median tumour height of 7.5 mm. The LTD was greater in older patients (t-test, P<0.001). The presence of epithelioid cells, closed loops, high mitotic rate, chromosome 3 deletion, and chromosome 8 gains all correlated significantly with LTD (t-test, P<0.001). The 1521 British patients had a median follow-up of 4.9 years, with a disease-specific mortality of 28.9%. Metastatic death correlated with LTD (Cox multivariate analysis, P<0.001). Tumours with the same LTD showed significant variation in survival, according to the presence of epithelioid cells (Log rank, P<0.001), closed loops (Log rank, P=0.002), high mitotic rate (Log rank, P=0.003), and chromosome 3 loss (Log rank, P=0.008).
CONCLUSIONS: The value of LTD as a predictor of survival after treatment of posterior uveal melanoma is enhanced by taking histological and cytogenetic factors into account.

Entities:  

Mesh:

Year:  2009        PMID: 19876071     DOI: 10.1038/eye.2009.235

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  24 in total

1.  Association between traditional clinical high-risk features and gene expression profile classification in uveal melanoma.

Authors:  Brandon T Nguyen; Ryan S Kim; Maria E Bretana; Eric Kegley; Amy C Schefler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-11-28       Impact factor: 3.117

2.  Identify the signature genes for diagnose of uveal melanoma by weight gene co-expression network analysis.

Authors:  Kai Shi; Zhi-Tong Bing; Gui-Qun Cao; Ling Guo; Ya-Na Cao; Hai-Ou Jiang; Mei-Xia Zhang
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

3.  Progress in the management of patients with uveal melanoma. The 2012 Ashton Lecture.

Authors:  B Damato
Journal:  Eye (Lond)       Date:  2012-06-29       Impact factor: 3.775

4.  Chromosome 3 status in uveal melanoma: a comparison of fluorescence in situ hybridization and single-nucleotide polymorphism array.

Authors:  Arun D Singh; Mary E Aronow; Yang Sun; Gurkan Bebek; Yogen Saunthararajah; Lynn R Schoenfield; Charles V Biscotti; Raymond R Tubbs; Pierre L Triozzi; Charis Eng
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-05       Impact factor: 4.799

Review 5.  Transhepatic therapies for metastatic uveal melanoma.

Authors:  David J Eschelman; Carin F Gonsalves; Takami Sato
Journal:  Semin Intervent Radiol       Date:  2013-03       Impact factor: 1.513

Review 6.  Does ocular treatment of uveal melanoma influence survival?

Authors:  B Damato
Journal:  Br J Cancer       Date:  2010-07-27       Impact factor: 7.640

7.  Multicentric recurrent uveal melanoma.

Authors:  Vikas Menon; Mithun Thulasidas; Ritesh Narula; Kautubh Mulay; Santosh G Honavar
Journal:  Indian J Ophthalmol       Date:  2020-10       Impact factor: 1.848

8.  Accuracy of The Cancer Genome Atlas Classification vs American Joint Committee on Cancer Classification for Prediction of Metastasis in Patients With Uveal Melanoma.

Authors:  Mehdi Mazloumi; Pornpattana Vichitvejpaisal; Lauren A Dalvin; Antonio Yaghy; Kathryn G Ewens; Arupa Ganguly; Carol L Shields
Journal:  JAMA Ophthalmol       Date:  2020-03-01       Impact factor: 7.389

9.  Assessment of the effect of iris colour and having children on 5-year risk of death after diagnosis of uveal melanoma: a follow-up study.

Authors:  Andrea Schmidt-Pokrzywniak; Sven Kalbitz; Oliver Kuss; Karl-Heinz Jöckel; Norbert Bornfeld; Andreas Stang
Journal:  BMC Ophthalmol       Date:  2014-04-01       Impact factor: 2.209

10.  Overexpression of high mobility group A1 protein in human uveal melanomas: implication for prognosis.

Authors:  Yi Qu; Yupeng Wang; Jinlan Ma; Yue Zhang; Nana Meng; Hao Li; Yan Wang; Wenbin Wei
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.